Golden
Emerald Therapeutics

Emerald Therapeutics

Emerald Therapeutics is a biotechnology company located in San Fransisco, California, founded by Brian Frezza and DJ Klienbaum in 2010. Emerald Therapeutics offers cloud a based software and hardware platform that allows researchers to remotely perform automated scientific laboratory experiments.

Emerald Therapeutics is a biotechnology company located in the San Francisco Bay Area, California, and was founded in 2013 by Brian Frezza and DJ Kleinbaum. The company offers a cloud based software and hardware integration platform, called the Emerald Cloud Lab (ECL), allowing researchers to perform experiments remotely in an automated lab.



The Emerald Cloud Lab provides researchers control over how experiments are carried out in the lab, and gives them the ability to adjust future lab protocols based on data generated from samples, laboratory instruments, and environmental control systems. The Emerald Cloud Lab also comes equipped with built-in tools for data analysis, manipulation, visualization, and modelling. Emerald Therapeutics claims their Emerald Cloud Lab allows scientists to achieve lower overhead costs and greater reproducibility compared to traditional laboratory experimental setups. 

Funding

Series A

On December 27, 2010 Emerald Therapeutics announced their series A funding round and closed with $7,500,000 in funding from James Hong. 

Series B

On March 1, 2014 Emerald Therapeutics announced their series B funding round and closed the round with $6,000,000 in funding from Schooner Capital, Founders Fund, and Max Levchin. 

Series C

On June 19, 2015 Emerald Therapeutics announced raising $20,500,000 in funding during their series C funding round from Western Technology Investment, Sound Ventures, Schooner Capital, OS Fund, and Founders Fund. 

Timeline

June 19, 2015

Series C funding round

On June 19, 2015 Emerald Therapeutics announced raising $20,500,000 in funding during their series C funding round from Western Technology Investment, Sound Ventures, Schooner Capital, OS Fund, and Founders Fund. 

March 1, 2014

Series B funding round

On March 1, 2014 Emerald Therapeutics announced their series B funding round and closed the round with $6,000,000 in funding from Schooner Capital, Founders Fund, and Max Levchin. 

December 27, 2010

Series A funding round

On December 27, 2010 Emerald Therapeutics announced their series A funding round and closed with $7,500,000 in funding from James Hong. 

2010

Founding of Emerald therapeutics

Emerald Therapeutics was founded in 2010 by Brian Frezza and DJ Kleinbaum

People

Name
Role
Related Golden topics

Ashby Monk

Investor



Brian Frezza

Co-Founder



Brian Singerman

Board Member



DJ Kleinbaum

Co-Founder



Eric Shyr

Employee



Gaetano Moreloo

Chief Scientific Officer and Board Member



James Hong

Investor



James McKernan

Employee



Jimmy Demesa

CEO



John Tomcat Sanderson

Employee



Joi Ito

Investor



MJD MJD

Investor



Shan Sinha

Investor



Further reading

Title
Author
Link
Type
Date

Founders Fund Backs a Robotic Lab that Puts Science in the Cloud

James Temple

News Article



Documentaries, videos and podcasts

Title
Date
Link





Companies

Company
CEO
Location
Products/Services









References